DPL Platform

POWERbody™

POWERbody™

POWERbody™ is a “booster” technology platform that combines Adagene’s SAFEbody™ masking technology with cutting-edge cancer treatment modalities to deliver optimal efficacious dosages to the tumor microenvironment, or TME.

POWERbody™ applies our SAFEbody technology to powerful antibody-based modalities such as creating new SAFE bispecific T-cell engagers, SAFE antibody-drug conjugates, or SAFE ADCs, or antibodies that are designed to reach beyond the therapeutic potency of traditional monospecific antibodies. downstream development.

POWERbody technologies are all designed to facilitate favorable druggability, manageable CMC attributes, and reduced immunogenicity.